Last $171.14 USD
Change Today -0.54 / -0.31%
Volume 294.5K
NVO On Other Exchanges
Symbol
Exchange
Copenhagen
New York
OTC US
Xetra
Frankfurt
As of 8:04 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NOVO-NORDISK A/S-SPONS ADR (NVO)

Novo Nordisk A/S to Report Fiscal Year 2013 on Jan 30, 2014
CapIQ 01/30/2014 5:00 AM ET
Novo Nordisk A/S to Report Nine Months, 2013 on Oct 31, 2013
CapIQ 01/30/2014 5:00 AM ET
Novo Nordisk A/S to Report First Half, 2013 on Aug 08, 2013
CapIQ 01/30/2014 5:00 AM ET

2012 revenues at Novo Nordisk A/S totaled kr78.0B DKK, while annual earnings equaled kr38.85 per share.

Quarterly Earnings & Estimates - NOVO-NORDISK A/S-SPONS ADR (NVO)

Actuals vs. Estimates for NOVO-NORDISK A/S-SPONS ADR NVO

No earnings announcements are currently available for NOVO-NORDISK A/S-SPONS ADR.

Annual Earnings & Estimates - NOVO-NORDISK A/S-SPONS ADR (NVO)

Actuals vs. Estimates for NOVO-NORDISK A/S-SPONS ADR NVO

Novo Nordisk A/S's Annual Earnings

Novo Nordisk A/S reported annual 2012 earnings of kr38.85 per share on 02/2/2013.

Quarterly Revenues - NOVO-NORDISK A/S-SPONS ADR (NVO)

Actuals vs. Estimates for NOVO-NORDISK A/S-SPONS ADR NVO

Annual Revenues - NOVO-NORDISK A/S-SPONS ADR (NVO)

Actuals vs. Estimates for NOVO-NORDISK A/S-SPONS ADR NVO

Novo Nordisk A/S's Annual Revenues

Novo Nordisk A/S had revenues for the full year 2012 of kr78.0B DKK. This was 17.6% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVO:US $171.14 USD -0.54

NVO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 3,395 GBp +4.00
Bristol-Myers Squibb Co $44.06 USD +0.30
Eli Lilly & Co $55.14 USD +0.12
Reckitt Benckiser Group PLC 4,828 GBp +58.00
Takeda Pharmaceutical Co Ltd ¥4,965 JPY +20.00
View Industry Companies
 

Industry Analysis

NVO

Industry Average

Valuation NVO Industry Range
Price/Earnings 24.1x
Price/Sales 6.7x
Price/Book 16.0x
Price/Cash Flow 19.5x
TEV/Sales 5.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVO-NORDISK A/S-SPONS ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.